Progyny names former WebMD CFO, Peter Anevski, as CFO and COO
Jan 09, 2017 13:01 pm UTC| Business
NEW YORK, Jan. 09, 2017 -- Progyny, a leading reproductive health technology and services company, today announced the appointment of former WebMD CFO, Peter Anevski, as its Chief Financial Officer and Chief Operating...
JLT Specialty USA Announces Appointment of David Turner as Vice President
Jan 09, 2017 13:01 pm UTC| Business
JLT Specialty USA welcomes another team member to its Financial Institutions practice in New York NEW YORK, Jan. 09, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the...
Vital Therapies Provides Corporate Update
Jan 09, 2017 13:01 pm UTC| Business
SAN DIEGO, Jan. 09, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today provided a corporate...
Retrophin Provides Corporate Update and 2017 Preview
Jan 09, 2017 13:01 pm UTC| Business
FDA discussions on sparsentan planned for January; RE-024 advancing with Phase 3 trial for the treatment of PKAN Preliminary Full-Year 2016 Revenue of Approximately $134 Million SAN DIEGO, Jan. 09, 2017 --...
Qorvo® Introduces Industry’s Smallest and Most Power-Efficient Family of Wi-Fi Front-End Modules
Jan 09, 2017 13:01 pm UTC| Business
GREENSBORO, NC, Jan. 09, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, has introduced a new family of 5 GHz and 2.4 GHz Wi-Fi Front-End Modules (FEMs) that pave the...
ITW Schedules Fourth Quarter and Full-Year 2016 Earnings Conference Call
Jan 09, 2017 13:01 pm UTC| Business
GLENVIEW, Ill., Jan. 09, 2017 -- Illinois Tool Works Inc. (NYSE:ITW) will issue its fourth quarter and full-year 2016 results at 7 a.m. (CST) on Wednesday, Jan. 25, 2017. Following the release, ITW will hold its fourth...
Jan 09, 2017 13:00 pm UTC| Business
BERKELEY, Calif., Jan. 09, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today a clinical collaboration with Merck (known as MSD outside...